Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
06/18/2014 | CN103874507A Parenteral norovirus vaccine formulations |
06/18/2014 | CN103874506A Blood stage malaria vaccine |
06/18/2014 | CN103874505A Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
06/18/2014 | CN103874504A Vaccine |
06/18/2014 | CN103874503A Anti-P-selectin antibodies and methods of their use and identification |
06/18/2014 | CN103874494A Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab |
06/18/2014 | CN103865938A Establishment method of clostridium difficile exotoxin A carboxyl-terminal sequence codon optimization gene segment and expression vector and application of expression protein thereof |
06/18/2014 | CN103865923A Preparation and application of influenza virus-carried HAdV (human adenovirus) chimeric vaccine |
06/18/2014 | CN103865892A Functional influenza virus like particles (VLPs) |
06/18/2014 | CN103865890A Recombinant virus for preventing viral myocarditis as well as vaccine and applications tof recombinant virus |
06/18/2014 | CN103865889A Rabies virus CTN chick-embryo cell adaptive strain |
06/18/2014 | CN103865888A Adapting method of rabies virus (RV) CTN-1 strain to primary chicken embryo fibroblast |
06/18/2014 | CN103865884A Duck viral hepatitis bivalent yolk antibody, preparation method and application thereof |
06/18/2014 | CN103865878A Monoclonal antibody for antagonistic inhibition of combination of vascular endothelial cell growth factor and receptor thereof, hybridoma cell line secreting monoclonal antibody, and use of monoclonal antibody |
06/18/2014 | CN103865859A Staphylococcus sciuri, vaccine and preparation method thereof |
06/18/2014 | CN103865834A Haemophilus parasuis with double-gene deletion and construction method thereof |
06/18/2014 | CN103864939A mGM-CSF/beta hCG fusion protein, and preparation method and application thereof |
06/18/2014 | CN103864936A HPV18 type L2NE7E6 fusion protein gene, and expression vector, preparation method, strain and use thereof |
06/18/2014 | CN103864935A Targeted EGFR/KDR (Epidermal Growth Factor Receptor/Kinase Insert Domain Receptor) specific diabody |
06/18/2014 | CN103864934A Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
06/18/2014 | CN103864932A Monoclonal antibody for antagonistically inhibiting combination of vascular endothelial growth factor with its receptor, and coding sequence and use thereof |
06/18/2014 | CN103864926A Method for preparing rabies human immune globulin by inactivation of double viruses |
06/18/2014 | CN103864925A Heavy chain and light chain variable region of high-neutralizing activity anti-Japanese encephalitis virus (JEV) monoclonal antibody |
06/18/2014 | CN103864924A Middle east and respiratory syndrome coronavirus antibody and preparation method thereof |
06/18/2014 | CN103864923A Glycosylated antibodies |
06/18/2014 | CN103864921A Folic acid-adriamycin immunological preparation for treating cancer through dual targets and preparation method thereof |
06/18/2014 | CN103864907A Protein and kit for tuberculosis diagnosis |
06/18/2014 | CN103864905A CTL (Cytotoxic T Lymphocyte) epitope peptide of foot-and-mouth disease virus type O and screening method of CTL epitope peptide |
06/18/2014 | CN103864904A Antigen fragment and truncation based on ebola virus envelope protein as well as application |
06/18/2014 | CN103864903A Hepatitis B virus surface antigen recombinant chimeric protein, preparation method and application thereof |
06/18/2014 | CN103861107A Pharmaceutical composition and uses thereof |
06/18/2014 | CN103861106A Antagonists of IL-6 to raise albumin and/or lower CRP |
06/18/2014 | CN103861102A Anti-CTLA-4 antibody compositions |
06/18/2014 | CN103861101A Novel chimeric flagellin adjuvant of helicobacter pylori multi-epitope vaccine |
06/18/2014 | CN103861100A Vaccine compositions comprising saponin adjuvant |
06/18/2014 | CN103861099A VACCINE ADJUVANT, VACCINE COMPOSITION AND usage of Antrodia camphorate sporocarp |
06/18/2014 | CN103861098A Bivalent vaccine for preventing porcine epidemic diarrhea and Escherichia coli |
06/18/2014 | CN103861097A Method for preparing porcine epizootic diarrhea inactivated vaccines and product thereof |
06/18/2014 | CN103861096A Preparation method of live vaccine for treating porcine reproductive and respiratory syndrome with high pathogenicity and live vaccine product |
06/18/2014 | CN103861095A Vaccine composition containing swine mycoplasmal pneumonia antigen and swine streptococcosis antigen, and preparation method and application thereof |
06/18/2014 | CN103861094A Clostridium perfringen alpha toxin genetic engineering vaccine and application thereof |
06/18/2014 | CN103861093A Sheep hydatid cyst subunit vaccine, and preparation method and application thereof |
06/18/2014 | CN103316334B Infectious bursal disease live vaccine and production method thereof |
06/18/2014 | CN103272233B Application of MLL (mixed lineage leukemia) 1 antibody and expression inhibiter in preparing medicine for treating AML (acute myeloid leukemia) |
06/18/2014 | CN103012587B Preparation, identification and application of monoclonal antibody of specific human lung resisting specific X protein |
06/18/2014 | CN103007275B Combined trivalent live vaccine for Newcastle disease and infectious chicken bronchitis |
06/18/2014 | CN102988976B Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof |
06/18/2014 | CN102988970B Foot-and-mouth disease purification vaccine, preparation method and applications thereof |
06/18/2014 | CN102899295B Duck hemorrhagic ovaritis virus |
06/18/2014 | CN102732533B Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof |
06/18/2014 | CN102659923B Epitope minimal motif peptides of human zona pellucida protein-4 and extended short peptides and application thereof |
06/18/2014 | CN102596996B Antibody having activity of inhibiting infection with hepatitis c virus (HCV) and use of same |
06/18/2014 | CN102596238B Apparatus and method for cryogranulating a pharmaceutical composition |
06/18/2014 | CN102392049B Preparation method for hepatitis E virus antigen and product thereof |
06/18/2014 | CN102302776B Injectable vaccines against multiple meningococcal serogroups |
06/18/2014 | CN102271711B Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect |
06/18/2014 | CN101970488B Humanized antibody molecules specific for il-31 |
06/18/2014 | CN101947306B Treatment of T-cell mediated diseases |
06/18/2014 | CN101890160B Multivalent recombinant human papilloma virus vaccine and application thereof |
06/18/2014 | CN101804202B Methods of producing influenza vaccine compositions |
06/18/2014 | CN101675075B Recombinant anti-epidermal growth factor receptor antibody compositions |
06/18/2014 | CN101479296B TRAIL receptor-binding agents and uses of the same |
06/18/2014 | CN101171034B Humanized L243 antibodies |
06/18/2014 | CN101155830B Antibodies that bind to epha2 and methods of use thereof |
06/17/2014 | US8754199 Tango 240 nucleic acids and uses thereof |
06/17/2014 | US8754196 Chromatography matrices including novel Staphylococcus aureus protein A based ligands |
06/17/2014 | US8754050 Macrocyclic compounds useful as inhibitors of histone deacetylases |
06/17/2014 | US8754046 MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1 |
06/17/2014 | US8754031 Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway |
06/17/2014 | US8753843 Antibodies to IL-17A |
06/17/2014 | US8753839 Compositions and methods for crystallizing antibodies |
06/17/2014 | US8753673 Liposome composition for delivery of a therapeutic agent to eyes |
06/17/2014 | US8753651 Capsular polysaccharide solubilisation and combination vaccines |
06/17/2014 | US8753650 Staphylococcus aureus proteins and nucleic acids |
06/17/2014 | US8753649 Polysaccharide-protein conjugate vaccines |
06/17/2014 | US8753648 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods |
06/17/2014 | US8753647 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant |
06/17/2014 | US8753646 IPV-DPT vaccine |
06/17/2014 | US8753645 Conjugation process of bacterial polysaccharides to carrier proteins |
06/17/2014 | US8753644 Grass peptides for vaccine |
06/17/2014 | US8753643 Spray dried compositions and methods of use |
06/17/2014 | US8753641 Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy |
06/17/2014 | US8753638 Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities |
06/17/2014 | US8753637 Binding partners for the thyrotropin receptor and uses thereof |
06/17/2014 | US8753636 Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
06/17/2014 | US8753635 Monoclonal antibodies to anthrax protective antigen |
06/17/2014 | US8753634 Anti-IL-6 receptor antibodies and methods of use |
06/17/2014 | US8753633 Human antibodies that bind human TNFα |
06/17/2014 | US8753632 Antibodies to modified human IGF-1/E peptides |
06/17/2014 | US8753631 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders |
06/17/2014 | US8753630 Using EGFRvIII to identify and target cancer stem cells |
06/17/2014 | US8753629 Optimized Fc variants |
06/17/2014 | US8753628 Optimized Fc variants |
06/17/2014 | US8753627 Anti-activin a antibodies and uses thereof |
06/17/2014 | US8753625 Use of complement inhibitors to treat ocular diseases |
06/17/2014 | US8753623 Influenza vaccine |
06/17/2014 | US8753622 Seneca valley virus based compositions and methods for treating disease |
06/17/2014 | CA2709354C Anti-amyloid antibodies and uses thereof |
06/17/2014 | CA2664795C Therapeutic compositions to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies |
06/17/2014 | CA2635599C Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |